Cubosome-based thermosensitive in situ gelling system for intranasal administration of lamotrigine with enhanced antiepileptic efficacy.
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutical development and technology"
DOI: 10.1080/10837450.2023.2216755
Abstract: Lamotrigine (LTG) is a second-generation antiepileptic drug that belongs to Biopharmaceutics Classification System (BCS) class II. LTG has a low probability of crossing the BBB if administered orally. This study was designed to fabricate LTG… read more here.
Keywords: ltg; drug; thermosensitive situ; antiepileptic efficacy ... See more keywords